Tak Paul Peter 4
4 · Candel Therapeutics, Inc. · Filed Dec 12, 2022
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-12-08$1.70/sh+3,050$5,185→ 28,050 total - Purchase
Common Stock
2022-12-09$1.92/sh+12,935$24,835→ 40,985 total
Footnotes (2)
- [F1]The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.